UNSPSC 51143708: Dextromethorphan/quinidine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN900. This VA Drug Class (CN900) classifies this compound as belonging to the group CNS MEDICATIONS, OTHER.

UNSPSC 51143708 Dextromethorphan/quinidine (Commodity) encompasses pharmaceutical products and systems that state and local health authorities procure to support public health initiatives, emergency response, and community wellness programs. Recent solicitations show state and local buyers sourcing naloxone and drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products through competitive bidding and cooperative purchasing vehicles. Issuing bodies include county health departments, state health commissions, and multistate purchasing alliances. The Seminole County, Florida procurement exemplifies direct acquisition by a single county health authority; the Texas Health and Human Services Commission and Minnesota Multistate Cooperative Purchasing Alliance represent state-level and regional cooperative purchasing approaches that aggregate demand across multiple jurisdictions and public entities.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with bids due July 26, 2023 (note: date discrepancy in source). The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, exploring direct relationships between state pharmacy benefit programs and pharmaceutical manufacturers. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon, with responses due March 26, 2026, and awarded vendors effective July 1, 2026. Vendors must comply with cGMP and Drug Supply Chain Security Act requirements, maintain relationships with authorized wholesalers, and carry insurance including $5,000,000 commercial general liability per occurrence.